Correction to: protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases-Reference-Cited by-同舟云学术

Correction to: protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases

Published:2019-11-06 Issue:1 Volume:17 Page:
ISSN:1477-9560
Container-title:Thrombosis Journal
language:en
Short-container-title:Thrombosis J

Author:

Heuberger Dorothea M.,Schuepbach Reto A.

Abstract

Following the publication of this article [1], the authors reported an incorrect citation in the following sentence in the “Metalloproteases” sub-section:

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1186/s12959-019-0212-x.pdf

Reference1 articles.

1. Heuberger and Schuepbach. Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Thrombosis Journal (2019) 17:4 https://doi.org/10.1186/s12959-019-0194-8

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controlling autoimmune diabetes onset by targeting Protease-Activated Receptor 2;Biomedicine & Pharmacotherapy;2024-06

2. Par2-mediated responses in inflammation and regeneration: choosing between repair and damage;Inflammation and Regeneration;2024-05-30

3. Xa inhibitor edoxaban ameliorates hepatic ischemia-reperfusion injury via PAR-2–ERK 1/2 pathway;PLOS ONE;2024-05-15

4. Low-Dose Trypsin Accelerates Wound Healing via Protease-Activated Receptor 2;ACS Pharmacology & Translational Science;2023-12-08

5. 1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2;Pharmaceuticals;2023-10-18